1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Patent Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Product Patents 1.2.3 Process Patents 1.3 Market by Application 1.3.1 Global Patent Medicine Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 Adult 1.3.3 Children 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Patent Medicine Market Size (2017-2028) 2.2 Patent Medicine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Patent Medicine Market Size by Region (2017-2022) 2.4 Global Patent Medicine Market Size Forecast by Region (2023-2028) 2.5 Global Top Patent Medicine Countries Ranking by Market Size 3 Patent Medicine Competitive by Company 3.1 Global Patent Medicine Revenue by Players 3.1.1 Global Patent Medicine Revenue by Players (2017-2022) 3.1.2 Global Patent Medicine Market Share by Players (2017-2022) 3.2 Global Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Patent Medicine Revenue 3.4 Global Patent Medicine Market Concentration Ratio 3.4.1 Global Patent Medicine Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Patent Medicine Revenue in 2021 3.5 Global Patent Medicine Key Players Head office and Area Served 3.6 Key Players Patent Medicine Product Solution and Service 3.7 Date of Enter into Patent Medicine Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Patent Medicine Breakdown Data by Type 4.1 Global Patent Medicine Historic Revenue by Type (2017-2022) 4.2 Global Patent Medicine Forecasted Revenue by Type (2023-2028) 5 Global Patent Medicine Breakdown Data by Application 5.1 Global Patent Medicine Historic Market Size by Application (2017-2022) 5.2 Global Patent Medicine Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Patent Medicine Revenue by Company (2020-2022) 6.2 North America Patent Medicine Revenue by Type (2017-2028) 6.3 North America Patent Medicine Revenue by Application (2017-2028) 6.4 North America Patent Medicine Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Patent Medicine Revenue by Company (2020-2022) 7.2 Europe Patent Medicine Revenue by Type (2017-2028) 7.3 Europe Patent Medicine Revenue by Application (2017-2028) 7.4 Europe Patent Medicine Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Patent Medicine Revenue by Company (2020-2022) 8.2 Asia Pacific Patent Medicine Revenue by Type (2017-2028) 8.3 Asia Pacific Patent Medicine Revenue by Application (2017-2028) 8.4 Asia Pacific Patent Medicine Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Patent Medicine Revenue by Company (2020-2022) 9.2 Latin America Patent Medicine Revenue by Type (2017-2028) 9.3 Latin America Patent Medicine Revenue by Application (2017-2028) 9.4 Latin America Patent Medicine Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Patent Medicine Revenue by Company (2020-2022) 10.2 Middle East and Africa Patent Medicine Revenue by Type (2017-2028) 10.3 Middle East and Africa Patent Medicine Revenue by Application (2017-2028) 10.4 Middle East and Africa Patent Medicine Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 U.A.E 11 Company Profiles 11.1 Pfizer Inc. 11.1.1 Pfizer Inc. Company Details 11.1.2 Pfizer Inc. Business Overview 11.1.3 Pfizer Inc. Patent Medicine Products and Services 11.1.4 Pfizer Inc. Patent Medicine Revenue in Patent Medicine Business (2017-2022) 11.1.5 Pfizer Inc. Patent Medicine SWOT Analysis 11.1.6 Pfizer Inc. Recent Developments 11.2 Otsuka Pharmaceutical 11.2.1 Otsuka Pharmaceutical Company Details 11.2.2 Otsuka Pharmaceutical Business Overview 11.2.3 Otsuka Pharmaceutical Patent Medicine Products and Services 11.2.4 Otsuka Pharmaceutical Patent Medicine Revenue in Patent Medicine Business (2017-2022) 11.2.5 Otsuka Pharmaceutical Patent Medicine SWOT Analysis 11.2.6 Otsuka Pharmaceutical Recent Developments 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck Patent Medicine Products and Services 11.3.4 Merck Patent Medicine Revenue in Patent Medicine Business (2017-2022) 11.3.5 Merck Patent Medicine SWOT Analysis 11.3.6 Merck Recent Developments 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Patent Medicine Products and Services 11.4.4 Novartis Patent Medicine Revenue in Patent Medicine Business (2017-2022) 11.4.5 Novartis Patent Medicine SWOT Analysis 11.4.6 Novartis Recent Developments 11.5 Sanofi-Aventis 11.5.1 Sanofi-Aventis Company Details 11.5.2 Sanofi-Aventis Business Overview 11.5.3 Sanofi-Aventis Patent Medicine Products and Services 11.5.4 Sanofi-Aventis Patent Medicine Revenue in Patent Medicine Business (2017-2022) 11.5.5 Sanofi-Aventis Patent Medicine SWOT Analysis 11.5.6 Sanofi-Aventis Recent Developments 11.6 Bristol-Myers Squibb Co. 11.6.1 Bristol-Myers Squibb Co. Company Details 11.6.2 Bristol-Myers Squibb Co. Business Overview 11.6.3 Bristol-Myers Squibb Co. Patent Medicine Products and Services 11.6.4 Bristol-Myers Squibb Co. Patent Medicine Revenue in Patent Medicine Business (2017-2022) 11.6.5 Bristol-Myers Squibb Co. Patent Medicine SWOT Analysis 11.6.6 Bristol-Myers Squibb Co. Recent Developments 11.7 GSK 11.7.1 GSK Company Details 11.7.2 GSK Business Overview 11.7.3 GSK Patent Medicine Products and Services 11.7.4 GSK Patent Medicine Revenue in Patent Medicine Business (2017-2022) 11.7.5 GSK Patent Medicine SWOT Analysis 11.7.6 GSK Recent Developments 12 Patent Medicine Market Dynamics 12.1 Patent Medicine Market Trends 12.2 Patent Medicine Market Drivers 12.3 Patent Medicine Market Challenges 12.4 Patent Medicine Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details

List of Tables Table 1. Global Patent Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Product Patents Table 3. Key Players of Process Patents Table 4. Global Patent Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Patent Medicine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 6. Global Patent Medicine Revenue by Region (2017-2022) & (US$ Million) Table 7. Global Patent Medicine Revenue Market Share by Region (2017-2022) Table 8. Global Patent Medicine Revenue by Players (2017-2022) & (US$ Million) Table 9. Global Patent Medicine Market Share by Players (2017-2022) Table 10. Global Top Patent Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Medicine as of 2021) Table 11. Ranking of Global Top Patent Medicine Companies by Revenue (US$ Million) in 2021 Table 12. Global 5 Largest Players Market Share by Patent Medicine Revenue (CR5 and HHI) & (2017-2022) Table 13. Key Players Headquarters and Area Served Table 14. Key Players Patent Medicine Product Solution and Service Table 15. Date of Key Manufacturers Enter into Patent Medicine Market Table 16. Mergers & Acquisitions, Expansion Plans Table 17. Global Patent Medicine Market Size by Type (2017-2022) & (US$ Million) Table 18. Global Patent Medicine Revenue Market Share by Type (2017-2022) Table 19. Global Patent Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 20. Global Patent Medicine Revenue Market Share by Type (2023-2028) Table 21. Global Patent Medicine Market Size by Application (2017-2022) & (US$ Million) Table 22. Global Patent Medicine Revenue Market Share by Application (2017-2022) Table 23. Global Patent Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 24. Global Patent Medicine Revenue Market Share by Application (2023-2028) Table 25. North America Patent Medicine Revenue by Company (2020-2022) & (US$ Million) Table 26. North America Patent Medicine Revenue by Type (2017-2022) & (US$ Million) Table 27. North America Patent Medicine Revenue by Type (2023-2028) & (US$ Million) Table 28. North America Patent Medicine Revenue by Application (2017-2022) & (US$ Million) Table 29. North America Patent Medicine Revenue by Application (2023-2028) & (US$ Million) Table 30. North America Patent Medicine Revenue by Country (2017-2022) & (US$ Million) Table 31. North America Patent Medicine Revenue by Country (2023-2028) & (US$ Million) Table 32. Europe Patent Medicine Revenue by Company (2020-2022) & (US$ Million) Table 33. Europe Patent Medicine Revenue by Type (2017-2022) & (US$ Million) Table 34. Europe Patent Medicine Revenue by Type (2023-2028) & (US$ Million) Table 35. Europe Patent Medicine Revenue by Application (2017-2022) & (US$ Million) Table 36. Europe Patent Medicine Revenue by Application (2023-2028) & (US$ Million) Table 37. Europe Patent Medicine Revenue by Country (2017-2022) & (US$ Million) Table 38. Europe Patent Medicine Revenue by Country (2023-2028) & (US$ Million) Table 39. Asia Pacific Patent Medicine Revenue by Company (2020-2022) & (US$ Million) Table 40. Asia Pacific Patent Medicine Revenue by Type (2017-2022) & (US$ Million) Table 41. Asia Pacific Patent Medicine Revenue by Type (2023-2028) & (US$ Million) Table 42. Asia Pacific Patent Medicine Revenue by Application (2017-2022) & (US$ Million) Table 43. Asia Pacific Patent Medicine Revenue by Application (2023-2028) & (US$ Million) Table 44. Asia Pacific Patent Medicine Revenue by Region (2017-2022) & (US$ Million) Table 45. Asia Pacific Patent Medicine Revenue by Region (2023-2028) & (US$ Million) Table 46. Latin America Patent Medicine Revenue by Company (2020-2022) & (US$ Million) Table 47. Latin America Patent Medicine Revenue by Type (2017-2022) & (US$ Million) Table 48. Latin America Patent Medicine Revenue by Type (2023-2028) & (US$ Million) Table 49. Latin America Patent Medicine Revenue by Application (2017-2022) & (US$ Million) Table 50. Latin America Patent Medicine Revenue by Application (2023-2028) & (US$ Million) Table 51. Latin America Patent Medicine Revenue by Country (2017-2022) & (US$ Million) Table 52. Latin America Patent Medicine Revenue by Country (2023-2028) & (US$ Million) Table 53. Middle East and Africa Patent Medicine Revenue by Company (2020-2022) & (US$ Million) Table 54. Middle East and Africa Patent Medicine Revenue by Type (2017-2022) & (US$ Million) Table 55. Middle East and Africa Patent Medicine Revenue by Type (2023-2028) & (US$ Million) Table 56. Middle East and Africa Patent Medicine Revenue by Application (2017-2022) & (US$ Million) Table 57. Middle East and Africa Patent Medicine Revenue by Application (2023-2028) & (US$ Million) Table 58. Middle East and Africa Patent Medicine Revenue by Country (2017-2022) & (US$ Million) Table 59. Middle East and Africa Patent Medicine Revenue by Country (2023-2028) & (US$ Million) Table 60. Pfizer Inc. Company Details Table 61. Pfizer Inc. Business Overview Table 62. Pfizer Inc. Patent Medicine Product and Services Table 63. Pfizer Inc. Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million) Table 64. Pfizer Inc. Patent Medicine SWOT Analysis Table 65. Pfizer Inc. Recent Developments Table 66. Otsuka Pharmaceutical Company Details Table 67. Otsuka Pharmaceutical Business Overview Table 68. Otsuka Pharmaceutical Patent Medicine Product and Services Table 69. Otsuka Pharmaceutical Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million) Table 70. Otsuka Pharmaceutical Patent Medicine SWOT Analysis Table 71. Otsuka Pharmaceutical Recent Developments Table 72. Merck Company Details Table 73. Merck Business Overview Table 74. Merck Patent Medicine Product and Services Table 75. Merck Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million) Table 76. Merck Patent Medicine SWOT Analysis Table 77. Merck Recent Developments Table 78. Novartis Company Details Table 79. Novartis Business Overview Table 80. Novartis Patent Medicine Product and Services Table 81. Novartis Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million) Table 82. Novartis Patent Medicine SWOT Analysis Table 83. Novartis Recent Developments Table 84. Sanofi-Aventis Company Details Table 85. Sanofi-Aventis Business Overview Table 86. Sanofi-Aventis Patent Medicine Product and Services Table 87. Sanofi-Aventis Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million) Table 88. Sanofi-Aventis Patent Medicine SWOT Analysis Table 89. Sanofi-Aventis Recent Developments Table 90. Bristol-Myers Squibb Co. Company Details Table 91. Bristol-Myers Squibb Co. Business Overview Table 92. Bristol-Myers Squibb Co. Patent Medicine Product and Services Table 93. Bristol-Myers Squibb Co. Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million) Table 94. Bristol-Myers Squibb Co. Patent Medicine SWOT Analysis Table 95. Bristol-Myers Squibb Co. Recent Developments Table 96. GSK Company Details Table 97. GSK Business Overview Table 98. GSK Patent Medicine Product and Services Table 99. GSK Patent Medicine Revenue in Patent Medicine Business (2017-2022) & (US$ Million) Table 100. GSK Patent Medicine SWOT Analysis Table 101. GSK Recent Developments Table 102. Patent Medicine Market Trends Table 103. Patent Medicine Market Drivers Table 104. Patent Medicine Market Challenges Table 105. Patent Medicine Market Restraints Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Global Patent Medicine Sales Market Share by Type: 2021 VS 2028 Figure 2. Product Patents Features Figure 3. Process Patents Features Figure 4. Global Patent Medicine Sales Market Share by Application: 2021 VS 2028 Figure 5. Adult Case Studies Figure 6. Children Case Studies Figure 7. Patent Medicine Report Years Considered Figure 8. Global Patent Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 9. Global Patent Medicine Market Size 2017-2028 (US$ Million) Figure 10. Global Patent Medicine Market Size Market Share by Region: 2021 VS 2028 Figure 11. Global Patent Medicine Revenue Market Share by Region in 2017 VS 2022 Figure 12. Global Top 10 Patent Medicine Countries Ranking by Market Size (US$ Million) in 2021 Figure 13. Global Patent Medicine Market Share by Players in 2021 Figure 14. Global Top Patent Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Medicine as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Patent Medicine Revenue in 2021 Figure 16. North America Patent Medicine Revenue Market Share by Company in 2021 Figure 17. North America Patent Medicine Revenue Market Share by Type (2017-2028) Figure 18. North America Patent Medicine Revenue Market Share by Application (2017-2028) Figure 19. North America Patent Medicine Revenue Share by Country (2017-2028) Figure 20. U.S. Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 21. Canada Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 22. Europe Patent Medicine Revenue Market Share by Company in 2021 Figure 23. Europe Patent Medicine Revenue Market Share by Type (2017-2028) Figure 24. Europe Patent Medicine Revenue Market Share by Application (2017-2028) Figure 25. Europe Patent Medicine Revenue Share by Country (2017-2028) Figure 26. Germany Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 27. France Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 28. U.K. Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 29. Italy Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 30. Russia Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 31. Asia Pacific Patent Medicine Revenue Market Share by Company in 2021 Figure 32. Asia Pacific Patent Medicine Revenue Market Share by Type (2017-2028) Figure 33. Asia Pacific Patent Medicine Revenue Market Share by Application (2017-2028) Figure 34. Asia Pacific Patent Medicine Revenue Share by Region (2017-2028) Figure 35. China Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 36. Japan Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 37. South Korea Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 38. India Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 39. Australia Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 40. Taiwan Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 41. Indonesia Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 42. Thailand Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 43. Malaysia Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 44. Philippines Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 45. Vietnam Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 46. Latin America Patent Medicine Revenue Market Share by Company in 2021 Figure 47. Latin America Patent Medicine Revenue Market Share by Type (2017-2028) Figure 48. Latin America Patent Medicine Revenue Market Share by Application (2017-2028) Figure 49. Latin America Patent Medicine Revenue Share by Country (2017-2028) Figure 50. Mexico Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 51. Brazil Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 52. Argentina Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 53. Middle East and Africa Patent Medicine Revenue Market Share by Company in 2021 Figure 54. Middle East and Africa Patent Medicine Revenue Market Share by Type (2017-2028) Figure 55. Middle East and Africa Patent Medicine Revenue Market Share by Application (2017-2028) Figure 56. Middle East and Africa Patent Medicine Revenue Share by Country (2017-2028) Figure 57. Turkey Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 58. Saudi Arabia Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 59. U.A.E Patent Medicine Revenue (2017-2028) & (US$ Million) Figure 60. Pfizer Inc. Revenue Growth Rate in Patent Medicine Business (2017-2022) Figure 61. Otsuka Pharmaceutical Revenue Growth Rate in Patent Medicine Business (2017-2022) Figure 62. Merck Revenue Growth Rate in Patent Medicine Business (2017-2022) Figure 63. Novartis Revenue Growth Rate in Patent Medicine Business (2017-2022) Figure 64. Sanofi-Aventis Revenue Growth Rate in Patent Medicine Business (2017-2022) Figure 65. Bristol-Myers Squibb Co. Revenue Growth Rate in Patent Medicine Business (2017-2022) Figure 66. GSK Revenue Growth Rate in Patent Medicine Business (2017-2022) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Pfizer Inc. Otsuka Pharmaceutical Merck Novartis Sanofi-Aventis Bristol-Myers Squibb Co. GSK